tiprankstipranks
Guorui Properties Ltd (HK:2329)
:2329
Want to see HK:2329 full AI Analyst Report?

Guorui Properties Ltd (2329) AI Stock Analysis

0 Followers

Top Page

HK:2329

Guorui Properties Ltd

(2329)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - Gpt-5.6Sol)
Rating:46Neutral
Price Target:
HK$0.09
â–¼(-32.86% Downside)
Action:Reiterated
Date:09/10/26
The score is held down primarily by weak financial performance (sharp revenue decline, deeply negative margins, rising leverage, and a steep drop in free cash flow). Technical indicators provide only partial offset with modestly positive near-term momentum, while valuation remains unattractive due to losses and no indicated dividend yield.
Positive Factors
Positive Equity Position
Although leverage is elevated and equity has declined, the company still retains positive equity rather than a negative-equity position. This provides a remaining capital base to support operations and restructuring, though its financial flexibility is materially constrained.
Negative Factors
Sharp Revenue and Margin Deterioration
The steep revenue contraction and deeply negative gross and net margins show severe deterioration in the core property development business. Larger losses weaken retained capital, reduce reinvestment capacity, and make a durable earnings recovery dependent on substantial operational improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Positive Equity Position
Although leverage is elevated and equity has declined, the company still retains positive equity rather than a negative-equity position. This provides a remaining capital base to support operations and restructuring, though its financial flexibility is materially constrained.
Read all positive factors

Guorui Properties Ltd (2329) vs. iShares MSCI Hong Kong ETF (EWH)

Guorui Properties Ltd Business Overview & Revenue Model

Company Description
Glory Health Industry Limited functions as an investment holding company, concentrating its efforts on real estate development within the People's Republic of China. The firm's activities are organized into four principal divisions: Property Devel...
How the Company Makes Money
Guorui Properties Ltd primarily makes money through real estate development activities. Its key revenue stream is generally the sale of developed properties, where revenue is recognized from selling residential and/or commercial units to end buyer...

Guorui Properties Ltd Financial Statement Overview

Summary
Financials have deteriorated materially: revenue fell ~50% in 2025 vs 2024 and margins turned deeply negative (gross margin ~-34%, net margin ~-175%), leading to larger losses. Leverage is high and rising (debt-to-equity ~2.94x) as equity declines, and cash generation collapsed in 2025 (FCF down ~98% YoY), increasing liquidity and refinancing risk.
Income Statement
12
Very Negative
Balance Sheet
28
Negative
Cash Flow
22
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue1.04B2.71B2.51B3.90B9.90B
Gross Profit-308.09M555.56M-50.28M113.52M1.25B
EBITDA-696.90M295.14M-145.86M-325.93M581.55M
Net Income-1.82B-1.24B-563.97M-912.78M228.33M
Balance Sheet
Total Assets56.70B57.20B56.35B57.39B61.07B
Cash, Cash Equivalents and Short-Term Investments138.18M158.10M152.22M189.51M556.87M
Total Debt23.83B22.79B22.18B21.25B20.95B
Total Liabilities46.10B44.83B42.57B43.01B45.64B
Stockholders Equity8.11B9.93B11.17B11.73B12.71B
Cash Flow
Free Cash Flow15.19M678.26M452.11M413.47M4.07B
Operating Cash Flow36.24M679.53M512.92M606.31M4.35B
Investing Cash Flow-861.82M146.72M58.95M-305.41M184.15M
Financing Cash Flow777.99M-830.50M-627.40M-630.90M-5.65B

Guorui Properties Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.14
Price Trends
50DMA
0.09
Positive
100DMA
0.10
Positive
200DMA
0.11
Positive
Market Momentum
MACD
<0.01
Negative
RSI
60.07
Neutral
STOCH
78.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2329, the sentiment is Positive. The current price of 0.14 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.09, and above the 200-day MA of 0.11, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 60.07 is Neutral, neither overbought nor oversold. The STOCH value of 78.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2329.

Guorui Properties Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
61
Neutral
HK$651.66M5.072.70%6.29%29.06%93.48%
47
Neutral
HK$486.40M-0.53-32.31%13.53%11.33%6.38%
46
Neutral
HK$493.33M-0.19-24.20%3.33%-54.15%-39.05%
43
Neutral
HK$261.36M-0.10-75.97%3.66%-38.39%-39.14%
39
Underperform
HK$327.98M-0.07-330.41%17.32%-48.10%-106.59%
39
Underperform
HK$257.26M>-0.0140.42%7.27%-18.03%-27.09%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2329
Guorui Properties Ltd
0.10
-0.10
-51.02%
HK:1813
KWG Group Holdings
0.10
-0.18
-65.71%
HK:1777
Fantasia Holdings Group Co. Ltd.
0.07
-0.31
-81.05%
HK:1243
Wang On Properties Ltd.
0.03
>-0.01
-15.79%
HK:1278
China New Town Development Co. Ltd.
0.07
-0.02
-24.73%
HK:3688
Top Spring International Holdings Limited
0.19
-0.27
-58.89%

Guorui Properties Ltd Corporate Events

Glory Health Industry Posts Wider Interim Loss Amid Property Market Pressure
Aug 31, 2026
Glory Health Industry Limited reported interim results for the six months ended June 30, 2026, highlighting contracted sales of RMB380.3 million and total revenue of RMB139.54 million, down sharply from the prior year as the rental market remained...
Glory Health Industry Sets Board Meeting to Review Interim Results and Dividend Plan
Aug 19, 2026
Glory Health Industry Limited has scheduled a board meeting for August 31, 2026 to review and approve the unaudited interim results for the six months ended June 30, 2026. The board will also consider the publication of these results and evaluate ...
Glory Health Industry Presses Ahead With Restructuring and Asset Sales to Address Audit Disclaimer
Jul 31, 2026
Glory Health Industry Limited has issued a quarterly update on steps it is taking to address a disclaimer of opinion in its latest audited financial statements. The company reports that restructuring negotiations with financial institutions and ot...
Glory Health Industry Tightens Governance With New Internal Control Manual
Jul 8, 2026
Glory Health Industry Limited has introduced a comprehensive Internal Control Manual, effective from 1 July 2025, covering its headquarters and all subsidiaries to strengthen corporate governance, risk oversight and compliance with Hong Kong Listi...
Glory Health Industry Wins Shareholder Backing for Governance and Capital Mandates at AGM
Jun 30, 2026
Glory Health Industry Limited, incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, operates in the health industry through a group of subsidiaries consolidated in its financial reporting. The company is overseen by a boa...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 10, 2026